ArticleCell discovery2023

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.

Liangxia Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.